Plain-English translation of NCT06394869 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a urine test called Cxbladder Triage Plus can help reduce the number of unnecessary bladder camera procedures (cystoscopies) in people who have microscopic blood in their urine. The test checks for genetic changes in urine that may indicate bladder cancer risk. By using this information, doctors and patients can make a shared decision about whether a bladder camera procedure is truly needed.
Microscopic blood in urine can be caused by many things, and while bladder cancer is a concern, it's actually found in only a small number of patients. Currently, most patients get a bladder camera procedure to rule out cancer, even though many don't need it. This trial wants to see if the new test can help avoid unnecessary procedures while still catching the cases that matter.
You likely qualify if…
You likely don't qualify if…
You will provide a urine sample for the genetic test. You will then be randomly assigned to one of two groups: either your doctor will receive the test results and discuss them with you to decide together whether you need a bladder camera procedure, or your doctor will make the decision using standard practice without the test results. The study follows your care and tracks whether you have a bladder camera procedure and what happens afterward.
AI-generated summary from trial data · Jul 4, 2026 · Not medical advice
United States